# Study of the Prevalence of Endogenous Hypercortisolism in Patients With Resistant Hypertension (MOMENTUM)

> **NCT06829537** · — · COMPLETED · sponsor: **Corcept Therapeutics** · enrollment: 1143 (actual)

## Conditions studied

- Resistant Hypertension
- Hypercortisolism

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06829537
- **Lead sponsor:** Corcept Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-03-28
- **Primary completion:** 2025-12-08
- **Final completion:** 2026-01-23
- **Target enrollment:** 1143 (ACTUAL)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06829537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06829537, "Study of the Prevalence of Endogenous Hypercortisolism in Patients With Resistant Hypertension (MOMENTUM)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06829537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*